While the rate of late-stage NSCLC diagnosis is improving, more needs to be done to increase survival rates. Are there outside factors that affect the stage at diagnosis, and what can we learn from them?
Breast cancer is one of the most common cancers in women, and one where awareness, education, and early detection can have a large impact on a patient’s survival rate. For patients at risk of breast cancer, how can you explain the ways in which breast cancer is screened for and detected, and how important is early detection to reducing mortality?
When looking into risk factors for prostate cancer, your patients may look to lifestyle factors. While some, like diet and smoking, are seen as risks for prostate cancer development, research into alcohol has drawn multiple conclusions. What have recent studies said about alcohol and prostate cancer, and does the type of alcohol affect risk?
As lung cancer is one of the most common cancer types, understanding patient needs and listening to their experiences may help improve the quality of care for hundreds of thousands of patients. What have recent studies suggested about patient experiences with lung cancer care, and what improvements have been made?
Melanoma is considered to be the most life-threatening form of skin cancer. However, in recent decades the emergence of immunotherapy has made great strides in improving survival. What are the mortality rates for patients with melanoma and how have they changed?
Multiple myeloma (MM) forms in a patient’s plasma cells, and the symptoms it brings can affect their quality of life in ways they may not be thinking about when first diagnosed. What are some lifestyle factors that are affected by multiple myeloma, and how can you discuss managing them with your patients?
How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.
Acute myeloid leukemia (AML) progresses more rapidly than other forms of leukemia. As such, if you or your patient are concerned they may have AML it is important to educate them on the symptoms and risk factors of the disease, as well as how to detect it and what treatments it could entail.
Multiple myeloma (MM) is not a disease with a known cure, but recent studies have suggested that focusing on boosting immunity in patients with MM may help their chances at longer-term survival. What are these immunity-focused treatment options?
As cancer treatments advance and survival rates increase, how is the quality of life among cancer survivors? Outside factors such as employment can play a large role in this. Among patients who are undergoing treatment or have survived cancer, what can the specifics of their occupational status tell us about their quality of life?
